(NASDAQ: AMED) Amedisys's forecast annual revenue growth rate of 4.95% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 57.82%.
Amedisys's revenue in 2025 is $2,348,324,000.On average, 7 Wall Street analysts forecast AMED's revenue for 2025 to be $94,556,578,721, with the lowest AMED revenue forecast at $93,687,158,210, and the highest AMED revenue forecast at $96,173,409,275.
In 2026, AMED is forecast to generate $99,514,807,930 in revenue, with the lowest revenue forecast at $97,838,583,600 and the highest revenue forecast at $102,235,564,651.